Literature DB >> 19631270

Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production.

Hans de Waard1, Niels Grasmeijer, Wouter L J Hinrichs, Anko C Eissens, Peter P F Pfaffenbach, Henderik W Frijlink.   

Abstract

In a previous study we have developed a novel process to produce drug nanocrystals. This process, "controlled crystallization during freeze-drying" has shown to be a successful method to increase the dissolution rate of poorly water-soluble drugs [de Waard, H., Hinrichs, W.L.J., Frijlink, H.W., 2008. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze drying. J. Control. Release 128, 179-183]. This process consisted of two steps: a solution of a matrix material (mannitol) in water was mixed with a solution of a drug (fenofibrate) in tertiary butyl alcohol (TBA). This mixture was frozen and subsequently freeze-dried at relatively high temperature (-25 degrees C). Since the solution of matrix and drug in the water-TBA mixture is thermodynamically unstable, it had to be frozen immediately and fast after preparation to prevent premature crystallization of the drug resulting in the formation too large drug crystals. Therefore, small quantities were manually mixed in a vial and this vial was immersed in liquid nitrogen. To make this process ready for large scale production, the modification of this batch process to a semi-continuous process by the application of a 3-way nozzle was studied. With this nozzle, the aqueous and TBA-solutions were pumped into the nozzle via two separate channels and mixed just at the moment they left the nozzle. Thorough mixing was facilitated by the atomizing air, supplied via the third channel. Since the mixture was sprayed immediately into liquid nitrogen, premature crystallization was prevented. A further advantage was that the atomizing air generated small droplets which were directly immersed into liquid nitrogen. Consequently, the mixture was frozen even faster than in the batch process. This resulted in a reduced size of the drug crystals and hence a higher dissolution rate. Therefore, using the semi-continuous process does not only result in successfully making this process suitable for large scale production of the controlled crystallized dispersions, but it also results in a better product.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631270     DOI: 10.1016/j.ejps.2009.07.005

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

Review 1.  Nanoparticles containing insoluble drug for cancer therapy.

Authors:  Shutao Guo; Leaf Huang
Journal:  Biotechnol Adv       Date:  2013-10-08       Impact factor: 14.227

Review 2.  Development Considerations for Nanocrystal Drug Products.

Authors:  Mei-Ling Chen; Mathew John; Sau L Lee; Katherine M Tyner
Journal:  AAPS J       Date:  2017-03-09       Impact factor: 4.009

3.  Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy.

Authors:  Hans de Waard; Thomas De Beer; Wouter L J Hinrichs; Chris Vervaet; Jean-Paul Remon; Henderik W Frijlink
Journal:  AAPS J       Date:  2010-07-13       Impact factor: 4.009

4.  Confined crystallization of fenofibrate in nanoporous silica.

Authors:  L M Dwyer; V K Michaelis; M O'Mahony; R G Griffin; A S Myerson
Journal:  CrystEngComm       Date:  2015-09-21       Impact factor: 3.545

5.  Nanocrystals for the parenteral delivery of poorly water-soluble drugs.

Authors:  Bo Sun; Yoon Yeo
Journal:  Curr Opin Solid State Mater Sci       Date:  2012-12-01       Impact factor: 11.354

6.  A user-friendly model for spray drying to aid pharmaceutical product development.

Authors:  Niels Grasmeijer; Hans de Waard; Wouter L J Hinrichs; Henderik W Frijlink
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

Review 7.  Combinative Particle Size Reduction Technologies for the Production of Drug Nanocrystals.

Authors:  Jaime Salazar; Rainer H Müller; Jan P Möschwitzer
Journal:  J Pharm (Cairo)       Date:  2014-01-06

8.  Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect.

Authors:  Heshu Sulaiman Rahman; Abdullah Rasedee; Chee Wun How; Ahmad Bustamam Abdul; Nazariah Allaudin Zeenathul; Hemn Hassan Othman; Mohamed Ibrahim Saeed; Swee Keong Yeap
Journal:  Int J Nanomedicine       Date:  2013-08-02

Review 9.  Drug nanocrystals: A way toward scale-up.

Authors:  Kale Mohana Raghava Srivalli; Brahmeshwar Mishra
Journal:  Saudi Pharm J       Date:  2014-05-09       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.